Literature DB >> 17689565

Hippocampus and amygdala neurotoxicity produced by systemic lidocaine in adult rats.

Vanessa Blas-Valdivia1, Edgar Cano-Europa, Adelaida Hernández-García, Rocio Ortiz-Butrón.   

Abstract

There is evidence that using lidocaine-treated cellular culture produces cell damage. However, there are no studies in vivo demonstrating the potential injurious effect of lidocaine on the central nervous system. Therefore, the aim of our study was to investigate if lidocaine is involved in neuronal damage in the CA3 hippocampus and amygdala regions when using a single subconvulsive or a convulsive lidocaine dose. Two-month-old male Wistar rats (57) were used. The animals were randomly assigned to one of three groups. Group I received 0.9% saline ip (n=9), group II received a single lidocaine dose of 60 mg/kg (n=18), and group III received 90 mg/kg ip (n=12). At day 2, 7, and 10 after the dosing, three to six rats per group were sacrificed. The brains of the rats were removed and were embedded in paraffin. Coronal cuts of 7 microm were made. Each brain section was stained with cresyl-eosin. We evaluated the number of normal and abnormal neurons in the hippocampal CA3 (pyramidal) and basolateral amygdala (large and medium neurons) regions in a 10,000 microm2 section. To explore an association between lidocaine-induced seizure and neuronal damage, diazepam was used (10 mg/kg ig) as an anticonvulsant two hours before a 90 mg/kg dose of lidocaine. Lidocaine causes a morphological neuronal alteration in the CA3 hippocampal region and the basolateral amygdala and possibly an inhibition-excitation imbalance. Diazepam prevents lidocaine-induced seizures, but not neuronal damage in brain structures. Interaction of lidocaine with the membrane components produces disrupted Ca+2 homeostasis and causes neuronal damage. Moreover, it is possible that lidocaine or its metabolites could actively participate in the neuronal damage observed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17689565     DOI: 10.1016/j.lfs.2007.07.007

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Ketamine could aggravate central nervous toxicity of lidocaine in rats convulsive model.

Authors:  Xiaomei Chen; Ning Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Delayed treatment with lidocaine reduces mouse microglial cell injury and cytokine production after stimulation with lipopolysaccharide and interferon γ.

Authors:  Hae-Jeong Jeong; Daowei Lin; Liaoliao Li; Zhiyi Zuo
Journal:  Anesth Analg       Date:  2012-01-16       Impact factor: 5.108

3.  Ketamine prevents lidocaine-caused neurotoxicity in the CA3 hippocampal and basolateral amygdala regions of the brain in adult rats.

Authors:  Gabriel Eduardo Lopez-Galindo; Edgar Cano-Europa; Rocio Ortiz-Butron
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

4.  The effect of lidocaine on apoptotic neurodegeneration in the developing mouse brain.

Authors:  Ji-Hyun Lee; Yong-Hee Park; Hyun-Gul Song; Hee-Pyoung Park; Hee-Soo Kim; Chong-Sung Kim; Jin-Tae Kim
Journal:  Korean J Anesthesiol       Date:  2014-11-26

5.  Electrocorticographic description of the effects of anticonvulsant drugs used to treat lidocaine-induced seizures.

Authors:  George Francisco S Santos; Luan Oliveira Ferreira; Bruna Gerrits Mattos; Eliniete J Fidelis; Alisson S de Souza; Paula S Batista; Cecilia A F Manoel; Diego Arthur C Cabral; Vanessa Jóia de Mello; Dielly Catrina Favacho Lopes; Moisés Hamoy
Journal:  Brain Behav       Date:  2020-12-25       Impact factor: 3.405

6.  Gallic Acid Prevents the Oxidative and Endoplasmic Reticulum Stresses in the Hippocampus of Adult-Onset Hypothyroid Rats.

Authors:  Vanessa Blas-Valdivia; Margarita Franco-Colín; Placido Rojas-Franco; Alberto Chao-Vazquez; Edgar Cano-Europa
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

7.  Neonatal bilateral lidocaine administration into the ventral hippocampus caused postpubertal behavioral changes: An animal model of neurodevelopmental psychopathological disorders.

Authors:  Vanessa Blas-Valdivia; Edgar Cano-Europa; Adelaida Hernández-García; Rocio Ortiz-Butrón
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.